关注
Ömer Dizdar
Ömer Dizdar
HACETTEPE UNIVERSITY CANCER INSTITUTE
在 hacettepe.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Rituximab-related viral infections in lymphoma patients
S Aksoy, H Harputluoglu, S Kilickap, DS Dede, O Dizdar, K Altundag, ...
Leukemia & lymphoma 48 (7), 1307-1312, 2007
2872007
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
O Saatci, A Kaymak, U Raza, PG Ersan, O Akbulut, CE Banister, ...
Nature communications 11 (1), 2416, 2020
2242020
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis
S Aksoy, Ö Dizdar, M Hayran, H Harputluoğlu
Leukemia & lymphoma 50 (3), 357-365, 2009
1322009
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor–related arthralgia
O Dizdar, L Özçakar, FÜ Malas, H Harputluoglu, N Bulut, S Aksoy, ...
Journal of Clinical Oncology 27 (30), 4955-4960, 2009
942009
Breast cancer subtypes and outcomes of central nervous system metastases
UY Arslan, B Oksuzoglu, S Aksoy, H Harputluoglu, I Turker, Y Ozisik, ...
The Breast 20 (6), 562-567, 2011
932011
Increased cancer risk in patients with periodontitis
O Dizdar, M Hayran, DC Guven, TB Yılmaz, S Taheri, AC Akman, E Bilgin, ...
Current Medical Research and Opinion 33 (12), 2195-2200, 2017
922017
Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience
S Aksoy, O Dizdar, H Harputluoglu, K Altundag
Annals of oncology 18 (11), 1904-1906, 2007
742007
Evaluation of cancer risk in patients with periodontal diseases
DC Güven, Ö Dizdar, AC Akman, AE BERKER, E Yekedüz, F Ceylan, ...
Turkish journal of medical sciences 49 (3), 826-831, 2019
672019
Systemic treatment in breast-cancer patients with brain metastasis
C Arslan, O Dizdar, K Altundag
Expert opinion on pharmacotherapy 11 (7), 1089-1100, 2010
592010
Obesity: an endocrine tumor?
Ö Dizdar, E Alyamaç
Medical hypotheses 63 (5), 790-792, 2004
572004
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
MF Ozcan, O Dizdar, N Dincer, S Balcı, G Guler, B Gok, G Pektas, ...
Urologic Oncology: Seminars and Original Investigations 31 (8), 1709-1715, 2013
562013
Advances in PARP inhibitors for the treatment of breast cancer
O Dizdar, C Arslan, K Altundag
Expert opinion on pharmacotherapy 16 (18), 2751-2758, 2015
542015
Pharmacotherapy of triple-negative breast cancer
C Arslan, O Dizdar, K Altundag
Expert opinion on pharmacotherapy 10 (13), 2081-2093, 2009
532009
The prevalence of usage of herbal medicines among cancer patients
S Tuna, O Dizdar, M Calis
system 83, 32, 2011
432011
A case report: zoledronic acid-induced anterior uveitis
S Kilickap, Y Ozdamar, MK Altundag, O Dizdar
Medical Oncology 25, 238-240, 2008
392008
Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C
O Dizdar, U Tapan, S Aksoy, H Harputluoglu, S Kilickap, I Barista
European journal of haematology 80 (5), 381-385, 2008
382008
Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality
DC Guven, TK Sahin, HC Yildirim, E Cesmeci, FGG Incesu, Y Tahillioglu, ...
BMJ Supportive & Palliative Care 14 (e1), e456-e461, 2024
372024
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience
H Harputluoglu, O Dizdar, S Aksoy, S Kilickap, DS Dede, Y Ozisik, ...
Journal of the National Medical Association 100 (5), 521-533, 2008
372008
COVID-19 pandemic: changes in cancer admissions
DC Guven, BY Aktas, MS Aksun, E Ucgul, TK Sahin, HC Yildirim, G Guner, ...
BMJ supportive & palliative care 14 (e1), e376-e379, 2024
362024
Biochemical markers of bone turnover in diagnosis of myeloma bone disease
O Dizdar, I Barista, U Kalyoncu, O Karadag, G Hascelik, A Cila, A Pinar, ...
American journal of hematology 82 (3), 185-191, 2007
362007
系统目前无法执行此操作,请稍后再试。
文章 1–20